COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Alexander T. Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, Agnes Y. Y. Lee, Lorenzo G. Mantovani, Miriam Bach, on behalf of the COSIMO Investigators

ABSTRACT

Background: Around 20% of venous thromboembolism (VTE) cases occur in patients with cancer. Current guidelines recommend low molecular weight heparin (LMWH) as the preferred anticoagulant for VTE treatment. However, some guidelines state that vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) are acceptable alternatives for long-term therapy in some patients if LMWHs are not available. LMWHs and VKAs have a number of drawbacks that can increase the burden on patients. DOACs, such as rivaroxaban, can ameliorate some burdens and may offer an opportunity to increase patient satisfaction and health-related quality of life (HRQoL). The Cancer-associated thrOmboSIs - patient-reported outcoMes with rivarOxaban (COSIMO) study is designed to provide real-world information on treatment satisfaction in patients with active cancer who switch from LMWH or VKA to rivaroxaban for the treatment of acute VTE or to prevent recurrent VTE. Methods: COSIMO is a prospective, non-interventional, single-arm cohort study that aims to recruit 500 patients in Europe, Canada and Australia. Adults with active cancer who are switching to rivaroxaban having received LMWH/VKA for the treatment and secondary prevention of recurrent VTE for at least the previous 4 weeks are eligible. Patients will be followed for 6 months. The primary outcome is treatment satisfaction assessed as change in the Anti-Clot Treatment Scale (ACTS) Burdens score at week 4 after enrolment compared with baseline. Secondary outcomes include treatment preferences, measured using a discrete choice experiment, change in ACTS Burdens score at months 3 and 6, and change in HRQoL (assessed using the Functional Assessment of Chronic Illness Therapy - Fatigue questionnaire). COSIMO will collect data on patients' medical history, patterns of anticoagulant use and incidence of bleeding and thromboembolic events. Study recruitment started in autumn 2016. Conclusions: COSIMO will provide information on outcomes associated with switching from LMWH or VKA therapy to rivaroxaban for the treatment or secondary prevention of cancer-associated thrombosis in a real-life setting. The key goal is to assess whether there is a change in patient-reported treatment satisfaction. In addition, COSIMO will facilitate the evaluation of the safety and effectiveness of rivaroxaban in preventing recurrent VTE in this patient population. Trial registration: NCT02742623. Registered 19 April 2016. More... »

PAGES

21

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12959-018-0176-2

DOI

http://dx.doi.org/10.1186/s12959-018-0176-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105230256

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30186045


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Department of Haematological Medicine, Guys and St Thomas\u2019 NHS Foundation Trust, King\u2019s College London, Westminster Bridge Road, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cohen", 
        "givenName": "Alexander T.", 
        "id": "sg:person.0621256066.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621256066.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hull York Medical School", 
          "id": "https://www.grid.ac/institutes/grid.413631.2", 
          "name": [
            "Joint Centre for Cancer Studies, Hull York Medical School, QCOH, Castle Hill Hospital, Hull, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maraveyas", 
        "givenName": "Anthony", 
        "id": "sg:person.01276160442.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276160442.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "King's College London", 
          "id": "https://www.grid.ac/institutes/grid.13097.3c", 
          "name": [
            "Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital \u201cCarl Gustav Carus\u201d Dresden, Dresden, Germany", 
            "Kings Thrombosis Service, Department of Haematology, Kings College London, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beyer-Westendorf", 
        "givenName": "Jan", 
        "id": "sg:person.01315313403.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315313403.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of British Columbia", 
          "id": "https://www.grid.ac/institutes/grid.17091.3e", 
          "name": [
            "Division of Hematology, University of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Agnes Y. Y.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "CESP-Center for Public Health Research, University of Milan Bicocca, Monza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mantovani", 
        "givenName": "Lorenzo G.", 
        "id": "sg:person.07442362324.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07442362324.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bayer (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420044.6", 
          "name": [
            "Bayer AG, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bach", 
        "givenName": "Miriam", 
        "id": "sg:person.014133470223.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014133470223.09"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "on behalf of the COSIMO Investigators", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2407-13-284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000589576", 
          "https://doi.org/10.1186/1471-2407-13-284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s79373", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000870957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.thromres.2014.11.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003217169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12955-015-0257-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008620087", 
          "https://doi.org/10.1186/s12955-015-0257-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12955-015-0257-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008620087", 
          "https://doi.org/10.1186/s12955-015-0257-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.59.7351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013097753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/jth.12923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013107051"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fcvm.2016.00024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014381602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-2-22", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014914147", 
          "https://doi.org/10.1186/1477-7525-2-22"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30369-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017453559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2352-3026(14)70018-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017522628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2007.02374.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017990984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-01-0108", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019785571"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehw210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020125462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehw210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020125462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-015-1263-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021177818", 
          "https://doi.org/10.1007/s11239-015-1263-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2015.127126", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021533844"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.49.1118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022692210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehu283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024127988"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa025313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024707641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pmed.1001275", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025561823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.thromres.2015.02.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027178314"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/2278-330x.149942", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031173618"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.293.6.715", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031368268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2011.04197.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032048791"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2015.9243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032108796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.thromres.2016.07.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032564135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.328.7436.360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036985070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2012.08.2223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037115565"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1007903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044711794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11739-012-0844-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045085835", 
          "https://doi.org/10.1007/s11739-012-0844-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehu243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046257046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-016-1429-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047090941", 
          "https://doi.org/10.1007/s11239-016-1429-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-016-1429-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047090941", 
          "https://doi.org/10.1007/s11239-016-1429-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-1-79", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047768593", 
          "https://doi.org/10.1186/1477-7525-1-79"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdr392", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048198947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2015.12.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051112496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.chest.2015.11.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051826247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-10-120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052009198", 
          "https://doi.org/10.1186/1477-7525-10-120"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.blre.2013.11.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053066608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0041-101770", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057371441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th13-03-0243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063293370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th15-08-0686", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063294144"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th16-06-0486", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063294359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th16-08-0615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063294387"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074253670", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th16-10-0793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084819431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0037-1603924", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090284255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th17-03-0193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091330941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1711948", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099653207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2018.78.8034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103934927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2018.78.8034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103934927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1160/th17-03-0193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106393181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2017.35.15_suppl.e18268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106849035"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "Background: Around 20% of venous thromboembolism (VTE) cases occur in patients with cancer. Current guidelines recommend low molecular weight heparin (LMWH) as the preferred anticoagulant for VTE treatment. However, some guidelines state that vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) are acceptable alternatives for long-term therapy in some patients if LMWHs are not available. LMWHs and VKAs have a number of drawbacks that can increase the burden on patients. DOACs, such as rivaroxaban, can ameliorate some burdens and may offer an opportunity to increase patient satisfaction and health-related quality of life (HRQoL). The Cancer-associated thrOmboSIs - patient-reported outcoMes with rivarOxaban (COSIMO) study is designed to provide real-world information on treatment satisfaction in patients with active cancer who switch from LMWH or VKA to rivaroxaban for the treatment of acute VTE or to prevent recurrent VTE.\nMethods: COSIMO is a prospective, non-interventional, single-arm cohort study that aims to recruit 500 patients in Europe, Canada and Australia. Adults with active cancer who are switching to rivaroxaban having received LMWH/VKA for the treatment and secondary prevention of recurrent VTE for at least the previous 4 weeks are eligible. Patients will be followed for 6 months. The primary outcome is treatment satisfaction assessed as change in the Anti-Clot Treatment Scale (ACTS) Burdens score at week 4 after enrolment compared with baseline. Secondary outcomes include treatment preferences, measured using a discrete choice experiment, change in ACTS Burdens score at months 3 and 6, and change in HRQoL (assessed using the Functional Assessment of Chronic Illness Therapy - Fatigue questionnaire). COSIMO will collect data on patients' medical history, patterns of anticoagulant use and incidence of bleeding and thromboembolic events. Study recruitment started in autumn 2016.\nConclusions: COSIMO will provide information on outcomes associated with switching from LMWH or VKA therapy to rivaroxaban for the treatment or secondary prevention of cancer-associated thrombosis in a real-life setting. The key goal is to assess whether there is a change in patient-reported treatment satisfaction. In addition, COSIMO will facilitate the evaluation of the safety and effectiveness of rivaroxaban in preventing recurrent VTE in this patient population.\nTrial registration: NCT02742623. Registered 19 April 2016.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12959-018-0176-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032055", 
        "issn": [
          "1477-9560"
        ], 
        "name": "Thrombosis Journal", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "COSIMO \u2013 patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study", 
    "pagination": "21", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7f4888e41483ff2856f38e439d7e7bc4d77e3f3c3d477b16c4b54285d916fa3f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30186045"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101170542"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12959-018-0176-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105230256"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12959-018-0176-2", 
      "https://app.dimensions.ai/details/publication/pub.1105230256"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000571.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12959-018-0176-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12959-018-0176-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12959-018-0176-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12959-018-0176-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12959-018-0176-2'


 

This table displays all metadata directly associated to this object as RDF triples.

274 TRIPLES      21 PREDICATES      78 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12959-018-0176-2 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Nc6a3137f53644a0ba436bd377acf4050
4 schema:citation sg:pub.10.1007/s11239-015-1263-x
5 sg:pub.10.1007/s11239-016-1429-1
6 sg:pub.10.1007/s11739-012-0844-3
7 sg:pub.10.1186/1471-2407-13-284
8 sg:pub.10.1186/1477-7525-1-79
9 sg:pub.10.1186/1477-7525-10-120
10 sg:pub.10.1186/1477-7525-2-22
11 sg:pub.10.1186/s12955-015-0257-x
12 https://app.dimensions.ai/details/publication/pub.1074253670
13 https://doi.org/10.1001/jama.2015.9243
14 https://doi.org/10.1001/jama.293.6.715
15 https://doi.org/10.1016/j.amjmed.2015.12.025
16 https://doi.org/10.1016/j.blre.2013.11.001
17 https://doi.org/10.1016/j.chest.2015.11.026
18 https://doi.org/10.1016/j.jval.2012.08.2223
19 https://doi.org/10.1016/j.thromres.2014.11.008
20 https://doi.org/10.1016/j.thromres.2015.02.001
21 https://doi.org/10.1016/j.thromres.2016.07.013
22 https://doi.org/10.1016/s1470-2045(16)30369-2
23 https://doi.org/10.1016/s2352-3026(14)70018-3
24 https://doi.org/10.1055/s-0037-1603924
25 https://doi.org/10.1055/s-0041-101770
26 https://doi.org/10.1056/nejmoa025313
27 https://doi.org/10.1056/nejmoa1007903
28 https://doi.org/10.1056/nejmoa1711948
29 https://doi.org/10.1093/annonc/mdr392
30 https://doi.org/10.1093/eurheartj/ehu243
31 https://doi.org/10.1093/eurheartj/ehu283
32 https://doi.org/10.1093/eurheartj/ehw210
33 https://doi.org/10.1111/j.1538-7836.2007.02374.x
34 https://doi.org/10.1111/j.1538-7836.2011.04197.x
35 https://doi.org/10.1111/jth.12923
36 https://doi.org/10.1136/bmj.328.7436.360
37 https://doi.org/10.1160/th13-03-0243
38 https://doi.org/10.1160/th15-08-0686
39 https://doi.org/10.1160/th16-06-0486
40 https://doi.org/10.1160/th16-08-0615
41 https://doi.org/10.1160/th16-10-0793
42 https://doi.org/10.1160/th17-03-0193
43 https://doi.org/10.1182/blood-2002-01-0108
44 https://doi.org/10.1200/jco.2013.49.1118
45 https://doi.org/10.1200/jco.2014.59.7351
46 https://doi.org/10.1200/jco.2017.35.15_suppl.e18268
47 https://doi.org/10.1200/jco.2018.78.8034
48 https://doi.org/10.1371/journal.pmed.1001275
49 https://doi.org/10.2147/ppa.s79373
50 https://doi.org/10.3324/haematol.2015.127126
51 https://doi.org/10.3389/fcvm.2016.00024
52 https://doi.org/10.4103/2278-330x.149942
53 schema:datePublished 2018-12
54 schema:datePublishedReg 2018-12-01
55 schema:description Background: Around 20% of venous thromboembolism (VTE) cases occur in patients with cancer. Current guidelines recommend low molecular weight heparin (LMWH) as the preferred anticoagulant for VTE treatment. However, some guidelines state that vitamin K antagonists (VKAs) and direct oral anticoagulants (DOACs) are acceptable alternatives for long-term therapy in some patients if LMWHs are not available. LMWHs and VKAs have a number of drawbacks that can increase the burden on patients. DOACs, such as rivaroxaban, can ameliorate some burdens and may offer an opportunity to increase patient satisfaction and health-related quality of life (HRQoL). The Cancer-associated thrOmboSIs - patient-reported outcoMes with rivarOxaban (COSIMO) study is designed to provide real-world information on treatment satisfaction in patients with active cancer who switch from LMWH or VKA to rivaroxaban for the treatment of acute VTE or to prevent recurrent VTE. Methods: COSIMO is a prospective, non-interventional, single-arm cohort study that aims to recruit 500 patients in Europe, Canada and Australia. Adults with active cancer who are switching to rivaroxaban having received LMWH/VKA for the treatment and secondary prevention of recurrent VTE for at least the previous 4 weeks are eligible. Patients will be followed for 6 months. The primary outcome is treatment satisfaction assessed as change in the Anti-Clot Treatment Scale (ACTS) Burdens score at week 4 after enrolment compared with baseline. Secondary outcomes include treatment preferences, measured using a discrete choice experiment, change in ACTS Burdens score at months 3 and 6, and change in HRQoL (assessed using the Functional Assessment of Chronic Illness Therapy - Fatigue questionnaire). COSIMO will collect data on patients' medical history, patterns of anticoagulant use and incidence of bleeding and thromboembolic events. Study recruitment started in autumn 2016. Conclusions: COSIMO will provide information on outcomes associated with switching from LMWH or VKA therapy to rivaroxaban for the treatment or secondary prevention of cancer-associated thrombosis in a real-life setting. The key goal is to assess whether there is a change in patient-reported treatment satisfaction. In addition, COSIMO will facilitate the evaluation of the safety and effectiveness of rivaroxaban in preventing recurrent VTE in this patient population. Trial registration: NCT02742623. Registered 19 April 2016.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree true
59 schema:isPartOf N3b7e95f82eed4df08d5d4bd0a84118fd
60 Ndec62e2505644038b52d75762cf0eb97
61 sg:journal.1032055
62 schema:name COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
63 schema:pagination 21
64 schema:productId N0469e744e7b54b88909f11784f5b8398
65 N47c03ec6bbf64bd2b8bd10091913a0ab
66 N7516555ba4f64ae5ab49dad1e51a1677
67 N7c20f623361641d4b95ad296616f1a61
68 Nd991bc6fbc414f78967cbb41af62b988
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105230256
70 https://doi.org/10.1186/s12959-018-0176-2
71 schema:sdDatePublished 2019-04-10T18:29
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher N9ae83450b9b74d62a4baeda3c892c9e4
74 schema:url https://link.springer.com/10.1186%2Fs12959-018-0176-2
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N0469e744e7b54b88909f11784f5b8398 schema:name doi
79 schema:value 10.1186/s12959-018-0176-2
80 rdf:type schema:PropertyValue
81 N3b7e95f82eed4df08d5d4bd0a84118fd schema:issueNumber 1
82 rdf:type schema:PublicationIssue
83 N3fe0bed80c1c45d4bbdf681a546af61f schema:familyName on behalf of the COSIMO Investigators
84 rdf:type schema:Person
85 N43a10adf103843a5871f72e73aaed4af rdf:first sg:person.01276160442.39
86 rdf:rest N55910564503148a687452811f88d762b
87 N47c03ec6bbf64bd2b8bd10091913a0ab schema:name dimensions_id
88 schema:value pub.1105230256
89 rdf:type schema:PropertyValue
90 N55910564503148a687452811f88d762b rdf:first sg:person.01315313403.41
91 rdf:rest Naed4769acb0e4527a175d47aa6fff8ab
92 N58969e893c5149b6867427b78fdda441 schema:affiliation https://www.grid.ac/institutes/grid.17091.3e
93 schema:familyName Lee
94 schema:givenName Agnes Y. Y.
95 rdf:type schema:Person
96 N7516555ba4f64ae5ab49dad1e51a1677 schema:name nlm_unique_id
97 schema:value 101170542
98 rdf:type schema:PropertyValue
99 N7c20f623361641d4b95ad296616f1a61 schema:name readcube_id
100 schema:value 7f4888e41483ff2856f38e439d7e7bc4d77e3f3c3d477b16c4b54285d916fa3f
101 rdf:type schema:PropertyValue
102 N932efa525a9b40e3833534c6e9650b7b rdf:first N3fe0bed80c1c45d4bbdf681a546af61f
103 rdf:rest rdf:nil
104 N9ae83450b9b74d62a4baeda3c892c9e4 schema:name Springer Nature - SN SciGraph project
105 rdf:type schema:Organization
106 Naed4769acb0e4527a175d47aa6fff8ab rdf:first N58969e893c5149b6867427b78fdda441
107 rdf:rest Nf74744466cab4e6b868ecee44dcd897c
108 Nbea327747b6047929a26341378f46445 rdf:first sg:person.014133470223.09
109 rdf:rest N932efa525a9b40e3833534c6e9650b7b
110 Nc6a3137f53644a0ba436bd377acf4050 rdf:first sg:person.0621256066.77
111 rdf:rest N43a10adf103843a5871f72e73aaed4af
112 Nccf6c3a7e10f4ecfa15761706e5960f3 schema:name CESP-Center for Public Health Research, University of Milan Bicocca, Monza, Italy
113 rdf:type schema:Organization
114 Nd991bc6fbc414f78967cbb41af62b988 schema:name pubmed_id
115 schema:value 30186045
116 rdf:type schema:PropertyValue
117 Ndec62e2505644038b52d75762cf0eb97 schema:volumeNumber 16
118 rdf:type schema:PublicationVolume
119 Nf74744466cab4e6b868ecee44dcd897c rdf:first sg:person.07442362324.37
120 rdf:rest Nbea327747b6047929a26341378f46445
121 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
122 schema:name Medical and Health Sciences
123 rdf:type schema:DefinedTerm
124 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
125 schema:name Public Health and Health Services
126 rdf:type schema:DefinedTerm
127 sg:journal.1032055 schema:issn 1477-9560
128 schema:name Thrombosis Journal
129 rdf:type schema:Periodical
130 sg:person.01276160442.39 schema:affiliation https://www.grid.ac/institutes/grid.413631.2
131 schema:familyName Maraveyas
132 schema:givenName Anthony
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276160442.39
134 rdf:type schema:Person
135 sg:person.01315313403.41 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
136 schema:familyName Beyer-Westendorf
137 schema:givenName Jan
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315313403.41
139 rdf:type schema:Person
140 sg:person.014133470223.09 schema:affiliation https://www.grid.ac/institutes/grid.420044.6
141 schema:familyName Bach
142 schema:givenName Miriam
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014133470223.09
144 rdf:type schema:Person
145 sg:person.0621256066.77 schema:affiliation https://www.grid.ac/institutes/grid.13097.3c
146 schema:familyName Cohen
147 schema:givenName Alexander T.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621256066.77
149 rdf:type schema:Person
150 sg:person.07442362324.37 schema:affiliation Nccf6c3a7e10f4ecfa15761706e5960f3
151 schema:familyName Mantovani
152 schema:givenName Lorenzo G.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07442362324.37
154 rdf:type schema:Person
155 sg:pub.10.1007/s11239-015-1263-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021177818
156 https://doi.org/10.1007/s11239-015-1263-x
157 rdf:type schema:CreativeWork
158 sg:pub.10.1007/s11239-016-1429-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047090941
159 https://doi.org/10.1007/s11239-016-1429-1
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/s11739-012-0844-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045085835
162 https://doi.org/10.1007/s11739-012-0844-3
163 rdf:type schema:CreativeWork
164 sg:pub.10.1186/1471-2407-13-284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000589576
165 https://doi.org/10.1186/1471-2407-13-284
166 rdf:type schema:CreativeWork
167 sg:pub.10.1186/1477-7525-1-79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047768593
168 https://doi.org/10.1186/1477-7525-1-79
169 rdf:type schema:CreativeWork
170 sg:pub.10.1186/1477-7525-10-120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052009198
171 https://doi.org/10.1186/1477-7525-10-120
172 rdf:type schema:CreativeWork
173 sg:pub.10.1186/1477-7525-2-22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014914147
174 https://doi.org/10.1186/1477-7525-2-22
175 rdf:type schema:CreativeWork
176 sg:pub.10.1186/s12955-015-0257-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008620087
177 https://doi.org/10.1186/s12955-015-0257-x
178 rdf:type schema:CreativeWork
179 https://app.dimensions.ai/details/publication/pub.1074253670 schema:CreativeWork
180 https://doi.org/10.1001/jama.2015.9243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032108796
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1001/jama.293.6.715 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031368268
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/j.amjmed.2015.12.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051112496
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.blre.2013.11.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053066608
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.chest.2015.11.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051826247
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.jval.2012.08.2223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037115565
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.thromres.2014.11.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003217169
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.thromres.2015.02.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027178314
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.thromres.2016.07.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032564135
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/s1470-2045(16)30369-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017453559
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/s2352-3026(14)70018-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017522628
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1055/s-0037-1603924 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090284255
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1055/s-0041-101770 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057371441
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1056/nejmoa025313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024707641
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1056/nejmoa1007903 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044711794
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1056/nejmoa1711948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099653207
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1093/annonc/mdr392 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048198947
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1093/eurheartj/ehu243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046257046
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1093/eurheartj/ehu283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024127988
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/eurheartj/ehw210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020125462
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1111/j.1538-7836.2007.02374.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017990984
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1111/j.1538-7836.2011.04197.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032048791
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1111/jth.12923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013107051
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1136/bmj.328.7436.360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036985070
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1160/th13-03-0243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063293370
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1160/th15-08-0686 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063294144
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1160/th16-06-0486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063294359
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1160/th16-08-0615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063294387
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1160/th16-10-0793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084819431
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1160/th17-03-0193 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091330941
239 https://app.dimensions.ai/details/publication/pub.1106393181
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1182/blood-2002-01-0108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019785571
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1200/jco.2013.49.1118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022692210
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1200/jco.2014.59.7351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013097753
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1200/jco.2017.35.15_suppl.e18268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106849035
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1200/jco.2018.78.8034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103934927
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1371/journal.pmed.1001275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025561823
252 rdf:type schema:CreativeWork
253 https://doi.org/10.2147/ppa.s79373 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000870957
254 rdf:type schema:CreativeWork
255 https://doi.org/10.3324/haematol.2015.127126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021533844
256 rdf:type schema:CreativeWork
257 https://doi.org/10.3389/fcvm.2016.00024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014381602
258 rdf:type schema:CreativeWork
259 https://doi.org/10.4103/2278-330x.149942 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031173618
260 rdf:type schema:CreativeWork
261 https://www.grid.ac/institutes/grid.13097.3c schema:alternateName King's College London
262 schema:name Department of Haematological Medicine, Guys and St Thomas’ NHS Foundation Trust, King’s College London, Westminster Bridge Road, London, UK
263 Kings Thrombosis Service, Department of Haematology, Kings College London, London, UK
264 Thrombosis Research Unit, Department of Medicine I, Division Hematology, University Hospital “Carl Gustav Carus” Dresden, Dresden, Germany
265 rdf:type schema:Organization
266 https://www.grid.ac/institutes/grid.17091.3e schema:alternateName University of British Columbia
267 schema:name Division of Hematology, University of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada
268 rdf:type schema:Organization
269 https://www.grid.ac/institutes/grid.413631.2 schema:alternateName Hull York Medical School
270 schema:name Joint Centre for Cancer Studies, Hull York Medical School, QCOH, Castle Hill Hospital, Hull, UK
271 rdf:type schema:Organization
272 https://www.grid.ac/institutes/grid.420044.6 schema:alternateName Bayer (Germany)
273 schema:name Bayer AG, Berlin, Germany
274 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...